Behavioral Pharmacology of Inhalants

  • David E. Hartman


Inhalants comprise a disparate group of mind-altering substances that are classified by their intake route. Despite more than 7 million users, there is a paucity of medical and neuropsychological literature. Only rarely are investigations into inhalant abuse reported in prominent substance abuse journals. This is probably due to multiple factors including (1) difficulty in studying or neglect of the population in which inhalant use is most prevalent, namely, individuals in lower socioeconomic strata; (2) the finding that use rarely occurs in isolation from other polydrug use or exposure to other inhalants; and (3) the fact that these substances are not generally classified as abused drugs because they are commonly available legal products.


Nitrous Oxide Carbon Monoxide Poisoning Behavioral Pharmacology Nitrous Oxide Anesthesia Locker Room 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aviado, D. M. (1977). Preclinicial pharmacology and toxicology of halogenated solvents and propellants. In C. W. Shar and M. L. Brehm (Eds.), Review of inhalants: Euphoria to dysfunction (NIDA Research Monograph No. 15, pp. 164–184 ). Rockville, MD: National Institute on Drug Abuse.Google Scholar
  2. Barnes, G. E. (1979). Solvent abuse: A review. International Journal of the Addictions, 14, 1–26.PubMedGoogle Scholar
  3. Brust, J. C. M. (1993). Other agents: Phencyclidine, marijuana, hallucinogens, inhalants and anticholinergics. Neurologic Clinics, 11, 555–561.PubMedGoogle Scholar
  4. Dillinger, S. (1993, May 15). Inhaling freon—Don’t. Alternate drugs. Usenet Newsgroup.Google Scholar
  5. Dohrn, C. S., Lichtor, J. L., Coalson, D. W, Uitvlugt, A., de Wit, H., and Zacny, J. P. (1993). Reinforcing effects of extended inhalation of nitrous oxide in humans. Drug and Alcohol Dependence, 31, 265–280.PubMedCrossRefGoogle Scholar
  6. Durden, W. D., and Chipman, D. W. (1967). Gasoline sniffing complicated by acute carbon tetrachloride poisoning. Archives of Internal Medicine, 119, 371.PubMedCrossRefGoogle Scholar
  7. Evans, A. C., and Raistrick, D. (1987). Phenomenology of intoxication with toluene-based adhesives and butane gas. British Journal of Psychiatry, 150, 769–773.CrossRefGoogle Scholar
  8. Flippo, T., and Holder, W. D. (1993). Neurologic degeneration associated with nitrous oxide anesthesia in patients with Vitamin B 12 deficiency. Archives of Surgery, 128, 1391–1395.PubMedCrossRefGoogle Scholar
  9. Garriott J. C. (1992) Death among inhalant abusers. In C. W. Sharp, F. Beauvas, and R. Spence (Eds.), Inhalant abuse: A volatile research agenda (NIDA Research Monograph No. 129, pp. 181–192 ). Rockville, MD: National Institute on Drug Abuse.Google Scholar
  10. Gillman, M. A. (1992). Nitrous oxide in perspective. Clinical Neuropharmacology, 15, 297–306.PubMedCrossRefGoogle Scholar
  11. Grigsby, J., Rosenberg, N. L., Dreisbach, J. N., Busenbark, D., and Grigsby, P. ( 1992, November). Chronic toluene abuse produces neuropsvchological deficits. Paper presented at the annual meeting of the National Academy of Neuropsychology, Pittsburgh, PA.Google Scholar
  12. Hawkins, K. A., Schwartz-Thompson, J., and Kahane, A. (1994). Abuse of formaldehyde-laced marijuana may cause dysmnesia. Journal of Neuropsychiatry, 2, 67.Google Scholar
  13. Hormes, J. T., Filley, C. M., and Rosenberg, N. L. (1986). Neurologic sequelae of chronic solvent vapor abuse. Neurology, 36, 698–702.PubMedCrossRefGoogle Scholar
  14. Ikeda, M. (1992). Public health problems of organic solvents. Toxicology Letters, 64–65, 191–201CrossRefGoogle Scholar
  15. King, G. S., Smialek, J. E., and Troutman, W G. (1985). Sudden death in adolescents resulting from the inhalation of typewriter correction fluid. Journal of the American Medical Association, 253, 1604–1606.PubMedCrossRefGoogle Scholar
  16. Knox, W. J., and Nelson, J. R. (1966). Permanent encephalopathy from toluene inhalation. New England Journal of Medicine, 269, 1340.Google Scholar
  17. Layzer, R. B. (1978). Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet, 2, 1227–1230.PubMedCrossRefGoogle Scholar
  18. Layzer, R. B. (1985). Nitrous oxide abuse. In E. 1. Eger (Ed.), Nitrous oxide/N,0 (pp. 249–257 ). New York: Elsevier.Google Scholar
  19. Linden, C. (1990). Volatile substances of abuse. Emergency Medicine Clinics of North America, 8, 559–578.Google Scholar
  20. Mathew, R. J., Wilson, W. H., and Tant, S. R. (1989). Regional cerebral blood flow changes associated with amyl nitrite inhalation. British Journal of Addiction, 84, 293–299.PubMedCrossRefGoogle Scholar
  21. Montoya-Cabrera, M. A. (1990). Neurotoxicology in Mexico and its relation to the general and work environment. In B. L. Johnson (Ed.), Advances in neurobehavioral toxicology: Applications in environmental and occupational health (pp. 35–57 ). Chelsea, MI: Lewis.Google Scholar
  22. Nylander, L. (1962). “Thinner” addition in children and adolescents. Acta Paedopsychiatrica, 29, 273–283.Google Scholar
  23. Prejean, J., and Gouvier, W. D. (1994). Neuropsychological sequelae of chronic recreational gasoline inhalation. Archives of Clinical Neuropsychology, 9, 173–174.Google Scholar
  24. Press, E., and Done, A. K. (1967). Solvent sniffing. Physiologic effects and community control measures for intoxication from the intentional inhalation of organic solvents. Journal of Pediatrics, 39, 451–461.Google Scholar
  25. Pryor, G. T. (1992). Animal research on solvent abuse. In C. W. Sharp, E Beauvas, and R. Spence (Eds.), Inhalant abuse: A volatile research agenda (NIDA Research Monograph No. 129, pp. 233–258 ). Rockville, MD: National Institute on Drug Abuse.Google Scholar
  26. Rosenberg, N. L., and Sharp, C. W. (1992). Solvent toxicity: A neurological focus. In C. W. Sharp, F. Beauvas, and R. Spence (Eds.), Inhalant abuse: A volatile research agenda (NIDA Research Monograph No. 129, pp. 117–171 ). Rockville, MD: National Institute on Drug Abuse.Google Scholar
  27. Siegel, E., and Wason, S. (1990). Sudden death caused by inhalation of butane and propane. New England Journal of Medicine, 323, 1638.PubMedCrossRefGoogle Scholar
  28. Stacey, C. B., DiRocco, A., and Gould, R. J. (1992). Methionine in the treatment of nitrous oxide-induced neuropathy and myeloneuropathy. Journal of Neurology, 239, 401–403.Google Scholar
  29. Tenenbein, M., and Pillay, N. (1993). Sensory evoked potentials in inhalant (volatile solvent) abuse. Journal of Paediatrics and Child Health, 29, 206–208.PubMedCrossRefGoogle Scholar
  30. Tohhara, S., Tani, N, Nakajima, T., and Tsuda, E. (1989). Clinical study of butane gas abuse: In comparison with toluene-based solvent and marihuana. Arakoru Kenkyuto Yakubutsu ‘son, 6, 504–510.Google Scholar
  31. Uitti, R. J., Snow, B. J., Shinotoh, H., Vingerhoets, F. J. G., Hayward, M., Hashimoto, S., Richmond, J., Markey, S. P, Markey, C. J., and Caine, D. B. (1994). Parkinsonism induced by solvent abuse. Annals of Neurology, 35, 616–619.PubMedCrossRefGoogle Scholar
  32. Wood, R. W. (1979). Reinforcing properties of inhaled substances. Neurobehavioral Toxicology, 1 (Suppl. 1), 67–72.Google Scholar
  33. Wood, R. W. (1988). The acute toxicity of nitrite inhalants. In H. W. Haverkos and J. A. Dougherty (Eds.), Health hazards of nitrite inhalants (NIDA Research Monograph No. 83, pp. 28–38 ). Rockville, MD: National Institute on Drug Abuse.Google Scholar
  34. Wyse, D. G. (1973). Deliberate inhalation of volatile hydrocarbons: A review. Canadian Medical Association Journal, 108, 71–74.Google Scholar
  35. Yanagita, T. S., Takahashi, K., Ishida, K., and Funamoto, H. (1970). Voluntary inhalation of volatile anesthetics and organic solvents by monkeys. Japanese Journal of Clinical Pharmacology, 1, 13–16.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • David E. Hartman
    • 1
  1. 1.Isaac Ray CenterRush Presbyterian St. Luke’s HospitalChicagoUSA

Personalised recommendations